M. Drijkoningen

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer

Huei‐Jean Huang, P. Neven, M. Drijkoningen et al. · Journal of Clinical Pathology · 2005 · 176 citations · Full text

Medicine, Oncology, Pathology +13

Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology

Gábor Cserni, Isabel Amendoeira, N Apostolikas et al. · Journal of Clinical Pathology · 2004 · 170 citations · Full text

Medicine, Oncology, Pathology +16

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing

Isabelle Vanden Bempt, Peter Van Loo, M. Drijkoningen et al. · Journal of Clinical Oncology · 2008 · 151 citations · Full text

Medicine, Oncology, Pathology +16

The E2F-Regulated Gene <i>Chk1</i> Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas

Lieve Verlinden, Isabelle Vanden Bempt, Guy Eelen et al. · Cancer Research · 2007 · 142 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation

Jasper Verguts, B Bronselaer, Gilbert Donders et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2006 · 139 citations

Medicine, Oncology, Pathology +17